Health-related quality of life (HRQOL) in metastatic renal cell carcinoma (mRCC) patients receiving sunitinib (SU) or interferon (IFN)-alfa in a randomized phase III trial: Updated geographic analysis Meeting Abstract


Authors: Cella, D.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Li, J. Z.; Kim, S. T.; Motzer, R. J.
Abstract Title: Health-related quality of life (HRQOL) in metastatic renal cell carcinoma (mRCC) patients receiving sunitinib (SU) or interferon (IFN)-alfa in a randomized phase III trial: Updated geographic analysis
Meeting Title: 33rd ESMO Congress
Journal Title: Annals of Oncology
Volume: 19
Issue: Suppl. 8
Meeting Dates: 2008 Sep 12-16
Meeting Location: Stockholm, Sweden
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2008-09-01
Start Page: viii189
Language: English
ACCESSION: WOS:000259973300584
PROVIDER: wos
DOI: 10.1093/annonc/mdn510
PUBMED: 18790885
Notes: Meeting Abstract: 585PD - 33rd European-Society-for-Medical-Oncology Congress - SEP 12-16, 2008 - Stockholm, SWEDEN - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer